Larvol Delta - CASI-Pharmaceuticals-Acquires-Global-Intellectual-Property-Rights-to-Cleave-Therapeutics39-VCPP97-Inhibitor-CB5339

CB-5339 - CASI

https://www.prnewswire.com/news-releases/casi-pharmaceuticals-acquires-global-intellectual-property-rights-to-cleave-therapeutics-vcpp97-inhibitor-cb-5339-301881595.html

Jul 20, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next